(Hypertension. 1999;34:1242.)
© 1999 American Heart Association, Inc.
Scientific Contributions |
From the Departments of Biochemistry (X.F., A.A.S.) and Internal Medicine (N.L.W., L.L.S., A.A.S.), University of Iowa College of Medicine, Iowa City.
Correspondence to Xiang Fang, MD, PhD, Department of Biochemistry, University of Iowa, Iowa City, IA 52242. E-mail xiang-fang{at}uiowa.edu
AbstractEpoxyeicosatrienoic acids (EETs) are cytochrome P450derived metabolites of arachidonic acid. They are potent endogenous vasodilator compounds produced by vascular cells, and EET-induced vasodilation has been attributed to activation of vascular smooth muscle cell (SMC) K+ channels. However, in some cells, EETs activate Ca2+ channels, resulting in Ca2+ influx and increased intracellular Ca2+ concentration ([Ca2+]i). We investigated whether EETs also can activate Ca2+ channels in vascular SMC and whether the resultant Ca2+ influx can influence vascular tone. The 4 EET regioisomers (1 µmol/L) increased porcine aortic SMC [Ca2+]i by 52% to 81%, whereas arachidonic acid, dihydroxyeicosatrienoic acids, and 15-hydroxyeicosatetraenoic acid (1 µmol/L) produced little effect. The increases in [Ca2+]i produced by 14,15-EET were abolished by removal of extracellular Ca2+ and by pretreatment with verapamil (10 µmol/L), an inhibitor of voltage-dependent (L-type) Ca2+ channels. 14,15-EET did not alter Ca2+ signaling induced by norepinephrine and thapsigargin. When administered to porcine coronary artery rings precontracted with a thromboxane mimetic, 14,15-EET produced relaxation. However, when administered to rings precontracted with acetylcholine or KCl, 14,15-EET produced additional contractions. In rings exposed to 10 mmol/L KCl, a concentration that did not affect resting ring tension, 14,15-EET produced small contractions that were abolished by EGTA (3 mmol/L) or verapamil (10 µmol/L). These observations indicate that 14,15-EET enhances [Ca2+]i influx in vascular SMC through voltage-dependent Ca2+ channels. This 14,15-EETinduced increase in [Cai2+] can produce vasoconstriction and therefore may act to modulate EET-induced vasorelaxation.
Key Words: calcium channels epoxyeicosatrienoic acid endothelium-derived factor vasoconstriction vasorelaxation
This article has been cited by other articles:
![]() |
V. M. Blanco, J. E. Stern, and J. A. Filosa Tone-dependent vascular responses to astrocyte-derived signals Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2855 - H2863. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Spector and A. W. Norris Action of epoxyeicosatrienoic acids on cellular function Am J Physiol Cell Physiol, March 1, 2007; 292(3): C996 - C1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.M. Payne, C. Weber, C. Crowley-Skillicorn, K. Dvorak, H. Bernstein, C. Bernstein, H. Holubec, B. Dvorakova, and H. Garewal Deoxycholate induces mitochondrial oxidative stress and activates NF-{kappa}B through multiple mechanisms in HCT-116 colon epithelial cells Carcinogenesis, January 1, 2007; 28(1): 215 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dhanasekaran, R. Al-Saghir, B. Lopez, D. Zhu, D. D. Gutterman, E. R. Jacobs, and M. Medhora Protective effects of epoxyeicosatrienoic acids on human endothelial cells from the pulmonary and coronary vasculature Am J Physiol Heart Circ Physiol, August 1, 2006; 291(2): H517 - H531. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, S. Hu, B. Xu, G. D. Snyder, S. Harmon, J. Yao, Y. Liu, B. Sangras, J. R. Falck, N. L. Weintraub, et al. 14,15-Dihydroxyeicosatrienoic acid activates peroxisome proliferator-activated receptor-{alpha} Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H55 - H63. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Earley, T. J. Heppner, M. T. Nelson, and J. E. Brayden TRPV4 Forms a Novel Ca2+ Signaling Complex With Ryanodine Receptors and BKCa Channels Circ. Res., December 9, 2005; 97(12): 1270 - 1279. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, N. L. Weintraub, R. B. McCaw, S. Hu, S. D. Harmon, J. B. Rice, B. D. Hammock, and A. A. Spector Effect of soluble epoxide hydrolase inhibition on epoxyeicosatrienoic acid metabolism in human blood vessels Am J Physiol Heart Circ Physiol, December 1, 2004; 287(6): H2412 - H2420. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Chuang, C. Helvig, M. Taimi, H. A. Ramshaw, A. H. Collop, M.'a. Amad, J. A. White, M. Petkovich, G. Jones, and B. Korczak CYP2U1, a Novel Human Thymus- and Brain-specific Cytochrome P450, Catalyzes {omega}- and ({omega}-1)-Hydroxylation of Fatty Acids J. Biol. Chem., February 20, 2004; 279(8): 6305 - 6314. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. J. Granville, B. Tashakkor, C. Takeuchi, A. B. Gustafsson, C. Huang, M. R. Sayen, P. Wentworth Jr., M. Yeager, and R. A. Gottlieb Reduction of ischemia and reperfusion-induced myocardial damage by cytochrome P450 inhibitors PNAS, February 3, 2004; 101(5): 1321 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fornage, E. Boerwinkle, P. A. Doris, D. Jacobs, K. Liu, and N. D. Wong Polymorphism of the Soluble Epoxide Hydrolase Is Associated With Coronary Artery Calcification in African-American Subjects: The Coronary Artery Risk Development In Young Adults (CARDIA) Study Circulation, January 27, 2004; 109(3): 335 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Fang, N. L. Weintraub, C. L. Oltman, L. L. Stoll, T. L. Kaduce, S. Harmon, K. C. Dellsperger, C. Morisseau, B. D. Hammock, and A. A. Spector Human coronary endothelial cells convert 14,15-EET to a biologically active chain-shortened epoxide Am J Physiol Heart Circ Physiol, December 1, 2002; 283(6): H2306 - H2314. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Roman P-450 Metabolites of Arachidonic Acid in the Control of Cardiovascular Function Physiol Rev, January 1, 2002; 82(1): 131 - 185. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. W. Miller, C. Dimitropoulou, G. Han, R. E. White, D. W. Busija, and G. O. Carrier Epoxyeicosatrienoic acid-induced relaxation is impaired in insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2001; 281(4): H1524 - H1531. [Abstract] [Full Text] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |